FOXA1 and neoplasm: There was a substantial gain of global Foxa1 binding in the liver metastasis (mets) cell line compared to the primary tumor cell line (Fig. 6a), with a total of 21,790 metastasis-specific gained Foxa1 binding sites (Fig. 6b,c).